Arkolith/Insider Trading/VINC/Form 4

Lowe Christopher P.

DirectorVincerx Pharma, Inc. (VINC) · full profile →Form 4 · filed Aug 26, 2022
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2022Buy(P)12K$1.65$19K40K
Aug 24, 2022Buy(P)18K$1.65$30K28K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-029840) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML